| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/31/2008 | CA2658058A1 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 01/31/2008 | CA2657815A1 Annellated pyrrole compounds for cancer management |
| 01/31/2008 | CA2657706A1 Dimeric iap antagonists |
| 01/31/2008 | CA2657200A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | CA2656239A1 Composition and methods for the enterosorption and management of toxins |
| 01/30/2008 | EP1882695A2 Pharmaceutically active compounds and methods of use thereof |
| 01/30/2008 | EP1882690A2 A process for the preparation of epothilone analogs and intermediates |
| 01/30/2008 | EP1882475A1 Method of treating disorders mediated by the fibroblast growth factor receptor |
| 01/30/2008 | EP1881986A2 Tyrosine kinase inhibitors |
| 01/30/2008 | EP1881983A1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 01/30/2008 | EP1881977A1 Histone deacetylase inhibitors |
| 01/30/2008 | EP1881976A1 Substituted amide derivatives as protein kinase inhibitors |
| 01/30/2008 | EP1881835A1 Triazine compounds and compositions thereof for the treatment of cancers |
| 01/30/2008 | EP1881829A2 Unsolvated and host-guest solvated crystalline forms of (2e,4s)-4-[(n-{[(2r)-1-isopropylpiperidin-2-yl]-carbonyl}-3-methyl-l-valyl)(methyl)amino]-2,5-dimethylhex-2-enoic acid and their pharmaceutical uses |
| 01/30/2008 | EP1881826A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2) |
| 01/30/2008 | EP1881824A1 Use of docosahexaenoic glycerides for the treatment of tumorous diseases |
| 01/30/2008 | EP1468110A4 Molecular signatures of commonly fatal carcinomas |
| 01/30/2008 | EP1163254B1 Trpm-2 antisense therapy |
| 01/30/2008 | EP0972063B1 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 01/30/2008 | EP0941125B1 Methods for regulating angiogenesis |
| 01/30/2008 | CN101115836A Inhibiting her2 shedding with matrix metalloprotease antagonists |
| 01/30/2008 | CN101115772A Cytotoxic antibody directed against type-B lymphoid haematopoietic prolifeeations |
| 01/30/2008 | CN101115760A Pyrrolopyrazoles, potent kinase inhibitors |
| 01/30/2008 | CN101115759A Cci-779 polymorph and use thereof |
| 01/30/2008 | CN101115752A 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 01/30/2008 | CN101115738A Pyrazolylamino substituted quinazoles for the treatment of cancer |
| 01/30/2008 | CN101115728A Triazole substituted aminobenzophenone compounds |
| 01/30/2008 | CN101115727A Compounds useful for inhibiting chk1 |
| 01/30/2008 | CN101115716A Substituted pyrroles, compositions containing same, method for making same and use thereof |
| 01/30/2008 | CN101115499A Combination of tyrosine kinase inhibitor and HER-2/NEU for cancer therapy |
| 01/30/2008 | CN101115486A Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| 01/30/2008 | CN101113478A Method for diagnosing testicular seminomas |
| 01/30/2008 | CN101113448A Agkistrodon halys ussuriensis disintegrin site-directed mutants cDNA clone, expression and protein preparation method and application thereof |
| 01/30/2008 | CN101113447A Antineoplastic small molecule interfering RNA and its anti-tumor use |
| 01/30/2008 | CN101113446A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113445A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113444A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113443A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113442A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113441A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113440A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113439A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113438A Antisense STAT3 oligonucleotide and uses thereof |
| 01/30/2008 | CN101113179A Human antibody sample molecule TEM8-Fc based on tumour endocytosis sign 8 and its application in tumour treatment |
| 01/30/2008 | CN101113178A Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (CTL) epitopes |
| 01/30/2008 | CN101113170A Preparation of new gene cell cycle related tumour high-expression gene monoclonal antibody and its application |
| 01/30/2008 | CN101113169A Use of sorting protein SNX10 for suppressing growth of tumour cell |
| 01/30/2008 | CN101113163A Hla-a24-restricted cancer antigen peptides |
| 01/30/2008 | CN101113159A Structure and usage of antisense oligonucleotide for preventing and treating lung carcinoma cell invasion transition |
| 01/30/2008 | CN101113155A Antineoplastic active ferrum complex and method for preparing same |
| 01/30/2008 | CN101113151A Snail lactam compound and preparation method and usage thereof |
| 01/30/2008 | CN101113148A Dioxygen piperazidine compounds and preparation method and usage thereof |
| 01/30/2008 | CN101113134A Triterpenes anti-neoplastic compound in cambric asterism sponge and method for preparing the same |
| 01/30/2008 | CN101112620A Cisplatin-hydroxyapatite -chitose sustained-release microsphere and uses thereof |
| 01/30/2008 | CN101112615A Antineoplastic health food product formulation |
| 01/30/2008 | CN101112614A Glair NRBP having important functions in regulating and controlling in immunoregulation |
| 01/30/2008 | CN101112504A Chinese medicine for curing cancer and the method for preparing the oral liquid thereof |
| 01/30/2008 | CN101112495A Chinese medicine for curing tumor |
| 01/30/2008 | CN101112419A Extracting technics of antineoplastic Chinese patent drug |
| 01/30/2008 | CN101112406A Medicinal plant plumbago indica having antitumor effect |
| 01/30/2008 | CN101112398A Application of typhoid fever and paratyphoid fever salmonella in the aspect of fast anti-tumor |
| 01/30/2008 | CN101112396A Extract of sparassis crispa MH-3 bacterial strain and method for preparing the same and use thereof |
| 01/30/2008 | CN101112385A Application of sodium thiosulfate in the preparation of clinical selenium-complementing and cancer-treating medicine and fast- preparing method for the same |
| 01/30/2008 | CN101112374A Camptothecinum-layered thermometal hydroxide nanometer complexes and method for preparing the same |
| 01/30/2008 | CN101112373A Methods of administering epothilone analogs for the treatment of cancer |
| 01/30/2008 | CN101112372A Application of compound s1 in the preparation of anti-cancer medicine |
| 01/30/2008 | CN101112371A Application of compound s2 in the preparation of anti-cancer medicine |
| 01/30/2008 | CN101112370A Extract of valid target in cudrania tricuspidata total flavone and method for preparing the same |
| 01/30/2008 | CN101112368A Application of compound s4 in the preparation of anti-cancer medicine |
| 01/30/2008 | CN101112364A Hepadestal preparations and method for preparing the same |
| 01/30/2008 | CN101112363A Crosslinking wrapped core slice in vivo for |
| 01/30/2008 | CN101112361A Magnetic nanometer particulate of liposoluble photosensitizer and method for preparing the same |
| 01/30/2008 | CN100365127C Polynucleotide comprising ubiquitous chromatin opening element (UCDE) |
| 01/30/2008 | CN100365022C Fusion toxin protein and uses thereof |
| 01/30/2008 | CN100365021C Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 01/30/2008 | CN100365016C Series peptide for promoting proliferation of bone marrow karyota and bone marrow substrate cell and its application |
| 01/30/2008 | CN100365015C 12-mer peptide, compound containing the same, its preparation method and application in cancer treatment drug |
| 01/30/2008 | CN100365014C Tumor targeting agents and uses thereof |
| 01/30/2008 | CN100365011C Process for producing asparagus saponin |
| 01/30/2008 | CN100365002C Process for preparing fotemustine for injection |
| 01/30/2008 | CN100365000C Combretastatin A-4 as phosphorylcholine precursor medicine and its synthesis and application |
| 01/30/2008 | CN100364997C Vinorelbine preparation method |
| 01/30/2008 | CN100364994C Crystal form of Peimeiqusai disodium and its preparation |
| 01/30/2008 | CN100364991C Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/30/2008 | CN100364612C Degraded agonist antibody |
| 01/30/2008 | CN100364607C Use of compound PS-341 in preparing medicine for treating chronic granulocytic leukemia |
| 01/30/2008 | CN100364597C Chinese traditional medicine for treating breast cancer |
| 01/30/2008 | CN100364586C Medicine for treating digestive tract tumor and its preparation method |
| 01/30/2008 | CN100364569C Extraction and separation method of anticancer active portion in fig fruit slag |
| 01/30/2008 | CN100364564C Lozenge for choke |
| 01/30/2008 | CN100364537C Cepharanthine drip pill and its preparation method |
| 01/30/2008 | CN100364536C Desoxyribose nucleic acid dual intercalating agent using methyl iso thiourea cation as linker |
| 01/30/2008 | CN100364529C Transdermal absorbing composition containing tumor radiotherapy sensitive-increasing agent |
| 01/30/2008 | CN100364525C Docetaxel liposome containing chitosan derivative, lyophiled preparation and preparation method thereof |
| 01/30/2008 | CN100364424C Method for preparing milk tablets contg. micron Grifola frondosa powder glossy ganoderma spore powder for anti-tumor mutation |
| 01/29/2008 | US7323587 Selective estrogen receptor modulators |
| 01/29/2008 | US7323549 IL-7 fusion proteins |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323484 Farnesyl transferase inhibitors |